Delivery Order SPE2DB22D2007-SPE2DB26FH6QL
- Not listed
- The Defense Logistics Agency awarded a $24,368.92 firm fixed-price delivery order to AmerisourceBergen Drug Corp on June 6, 2025, for the supply of AYVAKIT (avapritinib) 25 mg tablets in a 30-count package. The contract, with an ultimate completion date of June 30, 2025, represents a non-competitive, non-set-aside procurement executed through the company's existing Indefinite Delivery Contract with DLA Troop Support Medical. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a $48,737.84 firm fixed price delivery order to AmerisourceBergen Drug Corp for AYVAKIT (avapritinib) 25 mg tablets in quantities of 30 units. This award, issued on September 18, 2025, with an ultimate completion date of October 9, 2025, represents a non-competitive, non-set-aside procurement executed as a child order under AmerisourceBergen's broader contract vehicle with DLA. The product will be delivered to AmerisourceBergen's corporate office location...
- The Defense Logistics Agency Medical Supply Chain awarded a $48,737.84 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of AYVAKIT (avapritinib) 25 mg tablets in quantities of 30 units. This is a non-set-aside competitive award with an ultimate completion date of September 10, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of AYVAKIT (avapritinib) 25 mg tablets in a 30-count quantity, with a ceiling value of $24,368.92 and a firm fixed-price structure. This delivery order is not set-aside and represents a competitive award under the company's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $1 billion master contract vehicle valued through December 2026 that enables...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of AYVAKIT (avapritinib) 25 mg tablets in a quantity of 30 units, with a ceiling value of $24,368.92. This is a firm fixed-price delivery order under a competitively awarded, non-set-aside contract. The award is set to conclude by September 30, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. AYVAKIT is a...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of AYVAKIT 25 mg tablets in a quantity of 30 units. This firm fixed-price delivery order, valued at $73,106.76, is scheduled for completion by September 3, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation, reflecting the...
- The Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Ayvakit 25 mg tablets in a 30-count package. This firm fixed-price delivery order, valued at $48,737.84, represents a non-set-aside competitive award and is scheduled for completion by September 9, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for AYVAKIT 25 mg tablets (30-count) under a firm fixed-price contract valued at $24,368.92, with an ultimate completion date of August 21, 2025. This non-competitive delivery order was issued on July 31, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical procurement through DLA's medical supply chain to...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Ayvakit 25 mg tablets (30-count units) with a ceiling value of $24,368.92. The contract employs firm fixed pricing with an ultimate completion date of October 20, 2025, and is classified as a non-set-aside competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for AYVAKIT 25 mg tablets (30-count units) on September 16, 2025, with a ceiling value of $48,737.84 and completion date of October 7, 2025. This firm fixed-price, non-set-aside contract is a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999 through December 2026. The performance location is...
- SPE2DB22D2007Indefinite Delivery Contract
- SPE2DB22D2007-SPE2DB26FH6QLDelivery Order
The Defense Logistics Agency awarded a $24,369 firm fixed-price delivery order to AmerisourceBergen Drug Corp on October 29, 2025, for the supply of AYVAKIT (avapritinib) 25 mg tablets in a 30-count package. The contract is non-competitive with no set-aside designation and carries an ultimate completion date of November 20, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the Defense Logistics Agency's Medical Supply Chain. This delivery order represents a task issued under AmerisourceBergen's existing Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999 through December 2026. The parent IDC functions as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad spectrum of pharmaceutical products and medical supplies to support military healthcare programs worldwide. AYVAKIT, a specialty oncology medication, aligns with the company's portfolio of specialized therapeutic products delivered through its federal contracting relationships, which serve the Defense Health Agency, U.S. Coast Guard, and other government healthcare entities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $24.4k | 10/29/25 |